GUAZZONI, GIORGIO FERRUCCIO

GUAZZONI, GIORGIO FERRUCCIO  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 568 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 1-gen-2016 Hurle, R; Lazzeri, M; Colombo, P; Buffi, Nm; Morenghi, E; Peschechera, R; Castaldo, L; Pasini, L; Casale, P; Seveso, M; Zandegiacomo, S; Taverna, G; Benetti, A; Lughezzani, G; Fiorini, G; Guazzoni, G
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 1-gen-2011 Lazzeri, M; Lughezzani, G; Nava, L; Cestari, A; Larcher, A; Losa, A; Zanoni, M; Scattoni, V; Bini, V; Guazzoni, G
186 Indication and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy. An analysis of 5 institutions 1-gen-2013 Suardi, N; Haese, A; Ficarra, V; Govorov, A; Buffi, N; Walz, J; Rocco, B; Borghesi, M; Mottrie, A; Steuber, T; Guazzoni, G; Pushkar, D; H Van Der Poel, ; The Young Academic Urologist-robotic EAU section,
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 1-gen-2013 Buffi, N; Lista, G; Ficarra, V; Mottrie, A; Porter, J; Lughezzani, G; Larcher, A; Mistretta, Fa; Cestari, A; Lazzeri, M; Guazzoni, G
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 1-gen-1993 Montorsi, F; Guazzoni, G; Bergamaschi, F; Ferinistrambi, L; Barbieri, L; Rigatti, P
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 1-gen-2010 Sangalli, M; Scapaticci, E; Buffi, N; Zanoni, M; Cestari, A; Fabbri, F; Lughezzani, G; Rigatti, P; Montorsi, F; Guazzoni, G
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 1-gen-2011 Lughezzani, G; Lista, G; Buffi, N; Larcher, A; Sangalli, M; Scapaticci, E; Zanoni, M; Cestari, A; Gadda, G; Lazzeri, M; Rigatti, P; Montorsi, F; Guazzoni, G
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 1-gen-2018 Lazzeri, M; Lopci, E; Lughezzani, G; Buffi, N; Casale, P; Hurle, R; Saita, A; Peschechera, R; Benetti, A; Pasini, L; Zandegiacomo, S; Lista, G; Cardone, P; Chiti, A; Guazzoni, G
76 Retroperitoneal and transperitoneal robotic assisted pyeloplasty in adults: Techniques and results 1-gen-2010 Buffi, N; Cestari, A; Lista, G; Gadda, G; Sangalli, M; Scapaticci, E; Zanoni, M; Lazzeri, M; Guazzoni, G
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 1-gen-2013 Ceriotti, F; Pontillo, M; Fasoli, L; Lazzeri, M; Lughezzani, G; Lista, G; Larcher, A; Cestari, A; Buffi, N; Fuzzi, G; Guazzoni, G
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 1-gen-2011 Nava, L; Lazzeri, M; Scattoni, V; Maccagnano, C; Lughezzani, G; Buffi, N; Fabbri, F; Larcher, A; Bini, V; Cestari, A; Montorsi, F; Rigatti, P; Guazzoni, G
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 1-gen-2014 Lazzeri, M; Ceriotti, F; Buffi, N; Lughezzani, G; Larcher, A; Fossati, N; Lista, G; Abrate, A; Dell'Oglio, P; Mistretta, F; Pontillo, M; Bini, V; Guazzoni, G
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY. 1-gen-2012 Suardi, N; Briganti, A; Gallina, A; Abdollah, F; Di Muzio, Ng; Passoni, Nm; Fossati, N; Gianolli, L; Messa, Mc; Giovacchini, G; Scattoni, V; Guazzoni, G; Rigatti, P; Montorsi, F
[Focal therapy and prostate cancer]. 1-gen-2013 Lazzeri, M; Losa, A; Buffi, N; Lughezzani, G; Fossati, N; Abrate, A; Larcher, A; Lista, G; Mistretta, A; Guazzoni, G.
[The added value of robotic surgery]. 1-gen-2015 Buffi, N; Lughezzani, G; Lazzeri, M; Casale, P; Fiorini, G; Hurle, R; Taverna, Gl; Guazzoni, G
A COMPARISON OF TRANSRECTAL HYPERTHERMIA, TRANSURETHRAL THERMOTHERAPY, UROLUME WALLSTENT, AND PROSTATIC SPIRAL FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS AT POOR OPERATIVE RISK 1-gen-1994 Montorsi, F; Guazzoni, G; Bergamaschi, F; Consonni, P; Galli, L; Rigatti, P
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 1-gen-2005 Naspro, R; Salonia, A; Cestari, A; Guazzoni, G; Suardi, N; Colombo, R; Rigatti, P; Montorsi, F
A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer 1-gen-2010 Heuer, R; Gill, Is; Guazzoni, G; Kirkali, Z; Marberger, M; Richie, Jp; de la Rosette, Jjmch
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update 1-gen-2016 Walz, J; Epstein, Ji; Ganzer, R; Graefen, M; Guazzoni, G; Kaouk, J; Menon, M; Mottrie, A; Myers, Rp; Patel, V; Tewari, A; Villers, A; Artibani, W
A MODIFIED PROSTATIC UROLUME-WALLSTENT FOR HEALTHY PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA - A EUROPEAN MULTICENTER STUDY 1-gen-1994 Guazzoni, G; Montorsi, F; Coulange, C; Milroy, E; Pansadoro, V; Rubben, H; Sarramon, Jp; Williams, G